The summit focused on the future of healthcare and panellists shared insights into how digital health will transform the way patients are treated in the next 10 years.
The panel comprised of Dan Edwards, Managing Director at Sagentia’s HealthTech Advisory division; Andrew Thomson, Founder & CEO of Proteus Digital; Alice Rathjen, CEO of DNA Guide; Stanley Yang, CEO Neurosky and Darrin Disley, CEO & President of Horizon Discovery.
Sagentia’s Mr Edwards described a call to arms for those innovating in healthtech to ensure their “innovations and business models addressed the unsustainable cost of healthcare”.
”By 2025 healthcare spend and technology innovation will increasingly focus on predicting, diagnosing and monitoring, compared with today’s strong focus on treating,” says Dan Edwards. “The prime driver for this shift will be that in catching disease earlier in its lifecycle – in some cases before symptoms present – we will reduce the cost of health. We will also see healthcare becoming more consumer-led and a migration of healthcare away from traditional high-cost environments to the home. This means we’ll see the market entry of companies which are consumer and service savvy. Traditional MedTech companies are really struggling to adapt their approach to business to fit with the emerging connected healthcare opportunity and the field is ripe for new entrants to steal a lead in this booming market.”
Andrew Blackwell, CSO of Cambridge Cognition, commented: “There is real opportunity for behavioural modification in preventing chronic disease and leveraging the agility and speed of small healthtech businesses against the backdrop of grinding business model change in large medtech and pharma.”
Sherry Coutu, Chairman of the SVC2UK event, adds: “I believe that bringing the techniques of data-science to healthcare will bring about business opportunities for new entrants that will fundamentally improve outcomes not only for patients, but also doctors and the healthcare system in the next ten years. We have predicted that at least 10 billion pound companies will emerge from Europe in the next ten years and some of our SV guests made convincing arguments that the opportunities would produce trillion dollar companies.”
The SVC2UK event takes place each year, bringing together leading Silicon Valley entrepreneurs and UK thought leaders and investors to explore ideas and ignite more UK entrepreneurship. The aim is to debate, discuss, create and fund the most disruptive technologies to change our world in the years to come.
About Sagentia HealthTech Advisory
Sagentia HealthTech Advisory is part of the Sagentia Group, a global technology advisory and product development company. Building on our strong engineering, science and technology base combined with real industry insight, we provide an independent perspective on market needs definition, technology opportunities, and investment strategy and with a focus on delivering commercial value and market advantage. Our clients range from start-ups through to global market leaders in the MedTech and Pharma sectors. With headquarters in Cambridge, UK and offices in London, Boston, Houston and Dubai, the Group employs over 225 scientists, engineers and market experts. For further information contact [email protected] or visit www.sagentia.com
*******
Charlotte Gynane
Sagentia Ltd
Harston Mill, Harston
Cambridge CB22 7GG
United Kingdom
Tel: +44 1223 875585
Fax: +44 1223 875201
________________________________________________
Sagentia joins Silicon Valley thought leaders to discuss the future of healthcare
15 November 2013
The Sagentia Group, a global leader in technology advisory and product development services, joined a panel of iconic entrepreneurs and thought leaders at last week’s Silicon Valley Comes To The UK (SVC2UK) Health-Tech Summit held in Cambridge.